[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363489-105":59,"doc-detail-363489-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","causal-effects-of-plasma-proteinprotein-ratios-on-lung-cancer-subtypes-a-proteome-wide-mendelian-randomization-and-mediation-analysis","Causal effects of plasma protein–protein ratios on lung cancer subtypes - A proteome-wide Mendelian randomization and mediation analysis","","Lung cancer remains the leading cause of cancer-related mortality worldwide, with major subtypes including lung adenocarcinoma, lung squamous cell carcinoma (LUSC), and small cell lung cancer, yet the causal role of plasma protein–protein ratios in subtype-specific development remains poorly understood. A bidirectional two-sample Mendelian randomization analysis used proteomic pQTL instruments and lung cancer summary statistics from FinnGen and TRICL-ILCCO. Seventeen protein–protein ratios were associated across databases, including a higher MIA/NBL1 ratio linked to increased overall lung cancer and LUSC risk. Two-step MR suggested mediation of BMI effects on LUSC by the MIA/NBL1 ratio, supported by multiple sensitivity analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/causal-effects-of-plasma-proteinprotein-ratios-on-lung-cancer-subtypes-a-proteome-wide-mendelian-randomization-and-mediation-analysis/363489/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/causal-effects-of-plasma-proteinprotein-ratios-on-lung-cancer-subtypes-a-proteome-wide-mendelian-randomization-and-mediation-analysis/363489.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which plasma protein–protein ratios were linked to lung cancer subtypes in the study?","Question",{"text":112,"@type":113},"The study identified 17 plasma protein–protein ratios associated with lung cancer across both databases, including ratios specific to overall lung cancer, lung adenocarcinoma, LUSC, and small cell lung cancer. Among them, a higher MIA/DAN family BMP antagonist ratio was associated with increased risk for both overall lung cancer and LUSC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did individual-protein analyses show for the candidate ratio?",{"text":117,"@type":113},"When analyzing constituent proteins of the identified ratios individually, only the causal association between MIA and overall lung cancer remained significant.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the authors evaluate mediation and what did the 2-step MR suggest?",{"text":121,"@type":113},"A subsequent 2-step MR analysis indicated that the MIA/DAN family BMP antagonist ratio mediated the effect of body mass index on LUSC development, with mediation proportions reported consistently across both databases. Additional exploratory pathways were found for smoking initiation and BMI, interpreted cautiously due to MR assumptions and exploratory design.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363489,1790198392,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nCausal effects of plasma protein–protein ratios on lung cancer subtypes  \nA proteome-wide Mendelian randomization and mediation analysis  \nXin Geng, MSa , Jingyuan Xue, MSa , Kaisen Liu, MSa , Zipei Song, MSa , Yuheng Wang, MSb , Xincen Cao, MSa , Zhihua Li, MSa , Liang Chen, PHDa ,*  \n\n| Abstract\u003Cbr>Lung cancer remains the leading cause of cancer-related mortality worldwide, with major subtypes including lung adenocarcinoma, lung squamous cell carcinoma (LUSC), and small cell lung cancer, yet the causal role of plasma protein–protein ratios in subtypespecific development remains poorly understood. We performed a bidirectional, two-sample Mendelian randomization (MR) analysis to assess the causal effects of plasma protein–protein ratios on lung cancer. Genetic instruments for protein–protein ratios were derived from a large-scale proteomic genome-wide association study, and lung cancer summary statistics were obtained from the FinnGen and Transdisciplinary Research in Cancer of the Lung and International Lung Cancer Consortium databases. Our study identified 17 plasma protein–protein ratios associated with lung cancer across both databases, including 5 for overall lung cancer (LC), 4 for lung adenocarcinoma, 5 for LUSC, and 4 for small cell lung cancer. Notably, a higher melanoma inhibitory activity (MIA)/DAN family BMP antagonist ratio was associated with increased risk for both LC and LUSC. When analyzing the constituent proteins of these ratios individually, only the causal association between MIA and LC remained significant. Subsequent 2-step MR analysis revealed that the MIA/DAN family BMP antagonist ratio mediated the effect of body mass index on LUSC development, with consistent mediation proportions across both databases (13 .46%, 95% confidence interval: 3. 14%–23 .77% in FinnGen; 9.26%, 95% confidence interval: 0.05%–18 .47% in Transdisciplinary Research in Cancer of the Lung and International Lung Cancer Consortium) . Additional exploratory mediation pathways were identified for smoking initiation and body mass index; however, these findings should be interpreted with caution, given the assumptions underlying 2-step MR and the exploratory nature of the analysis. Multiple sensitivity analyses confirmed the robustness of these findings. This MR study offers novel proteomic insights into lung cancer pathogenesis and identifies candidate protein–protein ratios that warrant further functional investigation to assess their therapeutic potential. |\n| --- |\n| Abbreviations: BMI = body mass index, BTN2A1 = butyrophilin subfamily 2 member A1 , BWMR = Bayesian weighted Mendelian randomization, CI = confidence interval, CXCL5 = C-X-C motif chemokine ligand 5, FABP5 = fatty acid-binding protein 5, FDR = false discovery rate, GWAS = genome-wide association studies, HPCAL1 = hippocalcin-like 1, IV = instrumental variable, IVW = inverse-variance weighted, LAYN = layilin, LC = overall lung cancer, LUAD = lung adenocarcinoma, LUSC = lung squamous cell carcinoma, MIA = melanoma inhibitory activity, MR = Mendelian randomization, MR-PRESSO = MR pleiotropy residual sum and outlier, NBL1 = DAN family BMP antagonist, NSCLC = non-small cell lung cancer, OR = odds ratio, pQTL = protein quantitative trait locus, rQTL = ratio quantitative trait locus, S100A4 = S100 calcium-binding protein A4, SCLC = small cell lung cancer, SELE = E-selectin, SERPINB1 = serpin family B member 1, SIGLEC1 = sialic acid-binding Ig-like lectin 1, SNP = single-nucleotide polymorphism, TRICL-ILCCO = Transdisciplinary Research in Cancer of the Lung and International Lung Cancer Consortium, ULBP2 = UL16 binding protein 2, UVMR = univariable Mendelian randomization. |\n| Keywords: lung cancer, mediation analysis, Mendelian randomization, MIA/NBL1 , protein–protein ratios |\n\nXG, JX, and KL contributed to this article equally.  \nThis work was supported by the Major Program of Science and Technology Foundation of Jiangsu Province (BE2023832 and B","cbCaiu1dXacdpN11","https://ap.wps.com/l/cbCaiu1dXacdpN11","pdf",2536655,12,"English","# Abstract\n## Abbreviations\n## Keywords\n# Study background and approach\n## Proteomic instruments and data sources\n## Main findings across lung cancer subtypes\n## Mediation analyses and sensitivity checks\n## Reporting, support, and publication details","[{\"question\":\"Which plasma protein–protein ratios were linked to lung cancer subtypes in the study?\",\"answer\":\"The study identified 17 plasma protein–protein ratios associated with lung cancer across both databases, including ratios specific to overall lung cancer, lung adenocarcinoma, LUSC, and small cell lung cancer. Among them, a higher MIA/DAN family BMP antagonist ratio was associated with increased risk for both overall lung cancer and LUSC.\"},{\"question\":\"What did individual-protein analyses show for the candidate ratio?\",\"answer\":\"When analyzing constituent proteins of the identified ratios individually, only the causal association between MIA and overall lung cancer remained significant.\"},{\"question\":\"How did the authors evaluate mediation and what did the 2-step MR suggest?\",\"answer\":\"A subsequent 2-step MR analysis indicated that the MIA/DAN family BMP antagonist ratio mediated the effect of body mass index on LUSC development, with mediation proportions reported consistently across both databases. Additional exploratory pathways were found for smoking initiation and BMI, interpreted cautiously due to MR assumptions and exploratory design.\"}]","Causal effects of plasma protein–protein ratios on lung cancer subtypes - A proteome-wide Mendelian randomization and mediation analysis | PDF",1790151481,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30b2422b77e681459f4d8d1b17407b96.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea72fac803a5e5be8450a1986296a3d7.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0402ccae17241a5f576a636500b95046.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af949d1505c10c340d9b67fc69882845.webp",980,1306]